300049.SZ · 福瑞医科
China A-shares · RS rating 14 · As of 2026-10-14
| Price | 38.90 CNY |
|---|---|
| 1-day change | -3.6% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 52 / 38 / 5 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 16 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +9.6% |
| Distance from 52-week high | +53.8% |
| Market cap (USD) | $1.6B |